Published in Hepatology on November 23, 1983
Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proc Natl Acad Sci U S A (1989) 3.67
Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev (1999) 2.55
Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol (1990) 2.30
Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest (1992) 2.20
Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci U S A (1991) 2.05
Natural history and prognostic factors for chronic hepatitis type B. Gut (1991) 1.75
The HBV HBX gene expressed in E. coli is recognised by sera from hepatitis patients. EMBO J (1985) 1.45
Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev (2012) 1.30
Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load. J Clin Microbiol (2002) 1.18
Clinical implications of hepatitis B virus mutations: recent advances. World J Gastroenterol (2014) 1.08
Hepatitis B virus infection and primary hepatocellular carcinoma. Clin Microbiol Rev (1992) 1.04
Widespread presence of cytoplasmic HBcAg in hepatitis B infected liver detected by improved immunochemical methods. J Clin Pathol (1985) 1.03
Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion. J Clin Microbiol (2002) 1.02
The degrees of hepatocyte nuclear but not cytoplasmic expression of hepatitis B core antigen reflect the level of viral replication in chronic hepatitis B virus infection. J Clin Microbiol (1997) 1.00
Quantitative detection of hepatitis B virus DNA by real-time nucleic acid sequence-based amplification with molecular beacon detection. J Clin Microbiol (2001) 1.00
Membrane staining for hepatitis B surface antigen on hepatocytes: a sensitive and specific marker of active viral replication in hepatitis B. J Clin Pathol (1995) 0.97
Hepatitis B virus DNA and e antigen in serum from blood donors in the United Kingdom positive for hepatitis B surface antigen. Br Med J (Clin Res Ed) (1985) 0.96
Direct method for detecting small quantities of hepatitis B virus DNA in serum and plasma using the polymerase chain reaction. J Clin Invest (1989) 0.95
Distribution of HBcAg in hepatitis B detected by immunoperoxidase staining with three different preparations of anti-HBc antibodies. J Clin Pathol (1989) 0.95
Natural history of chronic hepatitis B: phases in a complex relationship. World J Gastroenterol (2014) 0.90
Clinical relevance of mutations in the precore genome of the hepatitis B virus. Gut (1995) 0.88
Acute hepatitis in rats expressing human hepatitis B virus transgenes. Proc Natl Acad Sci U S A (1995) 0.87
HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection. World J Gastroenterol (2014) 0.86
Viral markers in the treatment of hepatitis B and C. Gut (1993) 0.86
New assays for quantitative determination of viral markers in management of chronic hepatitis B virus infection. J Clin Microbiol (1992) 0.85
The degrees of hepatocyte cytoplasmic expression of hepatitis B core antigen correlate with histologic activity of liver disease in the young patients with chronic hepatitis B infection. J Korean Med Sci (2006) 0.85
Evaluation of the commercially available HepProbe kit for detection of hepatitis B virus DNA in serum. J Clin Microbiol (1990) 0.84
Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis. World J Hepatol (2010) 0.82
Associations of Expressions of HBcAg and HBsAg with the Histologic Activity of Liver Disease and Viral Replication. Gut Liver (2008) 0.82
Sequence analysis of hepatitis B virus genome of a new mutant of ayw subtype isolated in Sardinia. Nucleic Acids Res (1991) 0.81
Mutations in pre-core and basal-core promoter regions of hepatitis B virus in chronic HBV patients from Golestan, Iran. Iran J Basic Med Sci (2014) 0.81
Core antigen expression is associated with hepatic necroinflammation in e antigen-negative chronic hepatitis B patients with low DNA loads. Clin Vaccine Immunol (2010) 0.81
The two different states of hepatitis B virus DNA in asymptomatic carriers: HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers. Dig Dis Sci (1998) 0.80
Natural history of the HBsAg carrier. Gut (1985) 0.79
Universal emergence of precore mutant hepatitis B virus along with seroconversion to anti-HBe irrespective of subsequent activity of chronic hepatitis B. Korean J Intern Med (1994) 0.79
Study on hepatitis B virus pre-S/S gene mutations of renal tissues in children with hepatitis B virus-associated membranous nephropathy. Pediatr Nephrol (2006) 0.78
A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B. Dig Dis Sci (2000) 0.78
Hepatitis B core antigen expression in hepatocytes reflects viral response to entecavir in chronic hepatitis B patients. Gut Liver (2013) 0.77
Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma. World J Gastroenterol (2016) 0.77
Correlation Between Hepatitis B G1896A Precore Mutations and HBeAg in Chronic HBV Patients. Jundishapur J Microbiol (2015) 0.77
The Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide Analogs. J Clin Transl Hepatol (2014) 0.76
Unrevealing the natural course of the so-called "inactive HBsAg or HBV carrier state". Hepatol Int (2007) 0.76
Hepatitis B virus infection and primary liver cancer--an unfolding story. West J Med (1984) 0.75
Hepatocyte expression of HBcAg and serum HBeAg in hepatitis B: comparison of polyclonal and monoclonal antibodies during a trial of interferon. J Clin Pathol (1991) 0.75
Detection of hepatitis B virus DNA in human serum by dot hybridization using a biotin-labelled probe. Korean J Intern Med (1988) 0.75
Antiviral treatment in chronic infection with hepatitis B virus. Br Med J (Clin Res Ed) (1986) 0.75
Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients. Gut Liver (2017) 0.75
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta virus superinfection. J Clin Pathol (1989) 0.75
Hepatitis B virus genomes of chronic hepatitis patients do not contain specific mutations related to acute exacerbation. Dig Dis Sci (2001) 0.75
Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med (1981) 3.17
Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line. Nature (1980) 2.72
Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol (1998) 2.62
Isolation and partial characterization of reticulocyte factors M1 and M2. J Biol Chem (1970) 2.59
Factors for the initiation of haemoglobin synthesis by rabbit reticulocyte ribosomes. Nature (1970) 2.27
Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci U S A (1986) 2.18
Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial. Hepatology (1991) 2.15
Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers. Hepatology (1983) 2.10
Evidence for role of m7G5'-phosphate group in recognition of eukaryotic mRNA by initiation factor IF-M3. Nature (1976) 2.09
Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology (1987) 1.94
A characterization of globin mRNA sequences in the nucleus of duck immature red blood cells. Cell (1977) 1.89
Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the D-galactosamine model of liver regeneration. Am J Pathol (1993) 1.88
Evidence for supercoiled hepatitis B virus DNA in chimpanzee liver and serum Dane particles: possible implications in persistent HBV infection. Cell (1982) 1.81
Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas. Hepatology (1981) 1.73
Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats. J Biol Chem (1991) 1.52
Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma. Science (1985) 1.51
Percutaneous transhepatic cholangiography. An improved technique. JAMA (1975) 1.51
Long term follow-up studies of patients surviving fluminant viral hepatitis. Gastroenterology (1974) 1.51
Differentiation of pancreatic epithelial progenitor cells into hepatocytes following transplantation into rat liver. Proc Natl Acad Sci U S A (1997) 1.51
Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology (1987) 1.45
Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis (1994) 1.41
Factor dependent binding of methionyl-tRNAs to reticulocyte ribosomes. Nature (1970) 1.41
The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B. J Hepatol (2001) 1.39
Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B. Gastroenterology (2001) 1.38
Use of electroporation to introduce biologically active foreign genes into primary rat hepatocytes. Mol Cell Biol (1986) 1.37
The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virology (1988) 1.34
Requirement for GTP in the initiation process on reticulocyte ribosomes and ribosomal subunits. Proc Natl Acad Sci U S A (1971) 1.32
Non-A, non-B hepatitis-related hepatocellular carcinoma in a chimpanzee. J Med Primatol (1988) 1.29
Liver regeneration and alpha-fetoprotein messenger RNA expression in the retrorsine model for hepatocyte transplantation. Cancer Res (1998) 1.24
Monoclonal radioimmunoassays for hepatitis B surface antigen: demonstration of hepatitis B virus DNA or related sequences in serum and viral epitopes in immune complexes. Proc Natl Acad Sci U S A (1982) 1.23
Old and emerging therapies in chronic hepatitis C: an update. J Viral Hepat (2008) 1.22
Proliferation and differentiation of fetal liver epithelial progenitor cells after transplantation into adult rat liver. Am J Pathol (2000) 1.20
Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis. Aliment Pharmacol Ther (2001) 1.20
Hepatitis-associated antigen in chronic liver disease. Lancet (1970) 1.19
Puromycin-peptide bond formation with reticulocyte initiation factors M1 and M2. Proc Natl Acad Sci U S A (1971) 1.19
Models for hepatic progenitor cell activation. Proc Soc Exp Biol Med (1993) 1.19
Awareness of pediatric hypertension. Measuring blood pressure. JAMA (1976) 1.19
Stem cell properties and repopulation of the rat liver by fetal liver epithelial progenitor cells. Am J Pathol (2001) 1.18
Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am J Pathol (2001) 1.17
Principles of therapeutic liver repopulation. Semin Liver Dis (1999) 1.17
Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research. Eur J Gastroenterol Hepatol (2000) 1.16
Alpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription. J Virol (1990) 1.15
Distribution of rat liver albumin mRNA membrane-bound and free in polyribosomes as determined by molecular hybridization. Proc Natl Acad Sci U S A (1977) 1.14
Initial dipeptide formation in hemoglobin biosynthesis. Proc Natl Acad Sci U S A (1971) 1.13
Transcriptional switch from albumin to alpha-fetoprotein and changes in transcription of other genes during carbon tetrachloride induced liver regeneration. Biochemistry (1986) 1.11
Changing patterns of transcriptional and post-transcriptional control of liver-specific gene expression during rat development. Genes Dev (1987) 1.10
Diagnosis and management of pre-core mutant chronic hepatitis B. J Viral Hepat (2001) 1.10
Immunotherapy in nude mice of human hepatoma using monoclonal antibodies against hepatitis B virus. Nature (1982) 1.09
Interaction of poly(A) and mRNA with eukaryotic initiator met-tRNA-f binding factor: identification of this activity on reticulocyte ribonucleic acid protein particles. Proc Natl Acad Sci U S A (1975) 1.09
Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus. J Clin Invest (1983) 1.09
Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis. Ann Intern Med (1974) 1.08
Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. Gut (2003) 1.08
Identification and characterization of messenger ribonucleoprotein complexes from vesicular stomatitis virus-infected HeLa cells. Virology (1977) 1.08
Separation of two factors, M1 and M2, required for poly U dependent polypeptide synthesis by rabbit reticulocyte ribosomes at low magnesium ion concentration. Biochem Biophys Res Commun (1970) 1.08
Chronic hepatitis in chimpanzee carriers of hepatitis B virus: morphologic, immunologic, and viral DNA studies. Proc Natl Acad Sci U S A (1980) 1.07
Serologic characterization of patients with two episodes of acute viral hepatitis. Am J Med (1975) 1.07
Effect of a short term fast on the distribution of cytoplasmic albumin messenger ribonucleic acid in rat liver. Evidence for formation of free albumin messenger ribonucleoprotein particles. J Biol Chem (1978) 1.07
Evaluation of a ghetto school breakfast program. J Am Diet Assoc (1976) 1.06
Initiation activity of EMC virus RNA, binding to initiation factor eIF-4B and shut-off of host cell protein synthesis. Nature (1978) 1.06
Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece. J Viral Hepat (2005) 1.06
Identification of a high molecular weight presumptive precursor to albumin mRNA in the nucleus of rat liver and hepatoma cell line H4AZC2. J Biol Chem (1978) 1.05
Exon skipping during splicing of albumin mRNA precursors in Nagase analbuminemic rats. Proc Natl Acad Sci U S A (1990) 1.05
Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers. Hepatology (1985) 1.05
Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial. Hepatology (1995) 1.05
Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma. Virology (1988) 1.02
Development and use of a rat albumin cDNA clone to evaluate the effect of chronic ethanol administration on hepatic protein synthesis. Hepatology (1983) 1.02
Alpha-chain disease with clinical, immunological, and histological recovery. Br Med J (1974) 1.02
Cell transplantation causes loss of gap junctions and activates GGT expression permanently in host liver. Am J Physiol Gastrointest Liver Physiol (2000) 1.02
Evidence for nontranslated messenger fibonucleic acid in membrane-bound and free polysomes of rabbit liver. J Biol Chem (1974) 1.02
Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients. J Viral Hepat (1998) 1.02
Isolation of protein synthesis initiation factors from rabbit liver. J Biol Chem (1973) 1.01
Distribution of albumin and alpha-fetoprotein mRNAs in normal, hyperplastic, and preneoplastic rat liver. Am J Pathol (1992) 1.00
Cholestatic jaundice as a paraneoplastic manifestation of renal cell carcinoma. Eur J Gastroenterol Hepatol (1997) 1.00
Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA. Cancer Res (1981) 0.99
Changes in collagen and albumin mRNA in liver tissue of mice infected with Schistosoma mansoni as determined by in situ hybridization. J Cell Biol (1983) 0.99
Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen. Proc Natl Acad Sci U S A (1982) 0.99
Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication. Eur J Clin Invest (1996) 0.98
Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat. J Clin Invest (1992) 0.97
Use of molecular hybridization to purify and analyze albumin messenger RNA from rat liver. Proc Natl Acad Sci U S A (1977) 0.97
Differentiation-specific regulation of transgene expression in a diploid epithelial cell line derived from the normal F344 rat liver. J Pathol (1999) 0.97
Separation of reticulocyte initiation factor M 2 activity into two components. Proc Natl Acad Sci U S A (1972) 0.97
Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: a 4-year follow-up of 211 patients. Hepatology (1997) 0.96
A novel system for transplantation of isolated hepatocytes utilizing HBsAg-producing transgenic donor cells. Transplantation (1990) 0.96
Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin. J Viral Hepat (2008) 0.95
Infantile colic and type of milk feeding. Am J Dis Child (1987) 0.94
Review article: current management of chronic hepatitis B. Aliment Pharmacol Ther (2004) 0.94
Widespread differentiation stage-specific expression of the gene encoding phosphoprotein p19 (metablastin) in mammalian cells. Differentiation (1992) 0.94
Restoration of serum albumin levels in nagase analbuminemic rats by hepatocyte transplantation. Hepatology (1999) 0.93
Comparative morphology and tumourigenicity of human hepatocellular carcinoma cell lines in athymic rats and mice. Virchows Arch A Pathol Anat Histopathol (1988) 0.92
Tamoxifen in carcinoid syndrome. N Engl J Med (1981) 0.92